Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Innovative Medical clinical trials
Also known as IMEDS.
The registry lists 51 studies whose lead sponsor is Innovative Medical. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 14, 2012.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Innovative Medical.
- Innovative Medical51 studiesSame company
Something wrong?
Focus areas
Conditions Innovative Medical leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 →
- AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOLStatus unknownNCT01278420Phase 4
- Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)CompletedNCT01191229Phase 4
- Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of OsmolarityStatus unknownNCT01386073Phase 4
- Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following PhacoemulsificationStatus unknownNCT01193504Phase 4
- Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and SymptomsStatus unknownNCT01382810Phase 4
- Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast StudyStatus unknownNCT01191515
- An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic PatientsCompletedNCT01173198Phase 4
- Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract SurgeryCompletedNCT01383057Phase 4
- A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular LensCompletedNCT01061268Phase 4
- Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled TrialCompletedNCT01279031Phase 4
- Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract IncisionsCompletedNCT01298973Phase 4
- Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular LensesCompletedNCT01061281Phase 4
- Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract SurgeryStatus unknownNCT01382641Phase 4
- Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle IndependenceCompletedNCT01191502
- Laser Cataract Surgery With the Femtosecond Laser TechnologyCompletedNCT01382823Phase 4
- An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular LensesCompletedNCT01004549
- Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular LensesStatus unknownNCT01279122Phase 4
- Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular LensesCompletedNCT01061918Phase 4
- Prospective Health Assessment of Cataract Patients' Ocular SurfaceCompletedNCT01016405
- Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik ProcedureCompletedNCT01061294Phase 4
- Objective Measurements of Prolonged Effects of Restasis on Dry Eye DiseaseCompletedNCT00567177Phase 4
- Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00405457Phase 4
- Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive KeratectomyCompletedNCT00349440Phase 4
- Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%CompletedNCT00377546Phase 4
- Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of ScarsCompletedNCT00450775Phase 4
- Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00399061Phase 4
- Topical Cyclosporine and Disease ProgressionCompletedNCT00567983Phase 4
- Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens PatientsCompletedNCT00519948Phase 4
- Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug EffectsCompletedNCT00469690Phase 4
- Comfort Evaluation of a New MPS vs. Replenish in Contact Lens PatientsCompletedNCT00518700Phase 4
- Refractive Surgery and Optive Compatibility StudyCompletedNCT00469157Phase 4
- Safety and Efficacy of Optive in Contact Lens Wearers With Dry EyesCompletedNCT00469573Phase 4
- Oasys vs. Extreme H20 Xtra 59CompletedNCT00477763Phase 4
- Cross-Over Evaluation of Two Lubricating Eye DropsCompletedNCT00493662Phase 4
- An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin AgingTerminatedNCT00492479Phase 4
- Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNCT00433225Phase 4
- Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear ThicknessCompletedNCT00469521Phase 4
- A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry EyeCompletedNCT00399230Phase 4
- Therapeutic Variables in Cataract SurgeryCompletedNCT00407017Phase 4
- Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal StainingCompletedNCT00483795Phase 4
- Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract PatientsCompletedNCT00347503Phase 4
- Acular LS vs. Nevanac in Post op Inflammation Following Cataract SurgeryCompletedNCT00348582Phase 4
- A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular HypertensionCompletedNCT00348062Phase 4
- Comparison of Frequency of Use of Optive and SystaneCompletedNCT00406510Phase 4
- Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to LatanoprostCompletedNCT00347841Phase 4
- Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%CompletedNCT00347802Phase 4
- Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to LatanoprostCompletedNCT00348400Phase 4
- Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNCT00349583Phase 4
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNCT00383396Phase 4
- Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionCompletedNCT00348023Phase 4